Sugammadex: What do we know and what do we still need to know? A review of the recent (2013 to 2014) literature

    Research output: Contribution to journalArticle

    17 Citations (Scopus)

    Abstract

    Since its launch in 2008, sugammadex has been considered one of the most significant developments in anaesthesia-related pharmacology. With almost 500 sugammadex-related publications and over nine million patient exposures worldwide, user experience and scientific data have grown exponentially. However, several important questions are yet to be answered. This article reviews the sugammadex-related literature in 2013 and 2014 to determine which of these questions have been answered more fully over the last 18 months and which questions require more information and research.

    Original languageEnglish
    Pages (from-to)14-22
    Number of pages9
    JournalAnaesthesia and Intensive Care
    Volume43
    Issue number1
    DOIs
    Publication statusPublished - 1 Jan 2015

    Fingerprint

    Dive into the research topics of 'Sugammadex: What do we know and what do we still need to know? A review of the recent (2013 to 2014) literature'. Together they form a unique fingerprint.

    Cite this